Zimmer Biomet Says '6% Growth In The U.S. And 9% Internationally, Driven By Strong Product Portfolio, Robotics Division With ROSA And Launch Of Their Cementless Knee Persona OsseoTi, Capturing Market Share From Competitors, With 10%-15% Higher Pricing'
Benzinga Newsdesk - Jan 9, 2024, 11:51AM